Skip to main content
Erschienen in: Clinical Rheumatology 3/2018

03.11.2017 | Original Article

Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis

verfasst von: José Antonio De Jesús Batún-Garrido, Marisol Salas-Magaña, Isela Esther Juárez-Rojop

Erschienen in: Clinical Rheumatology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Pro-inflammatory cytokines such as leptin and IL-6 play an important role in the development of cardiovascular risk. Determine the relationship between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis. We determined IL-6 and leptin levels in 77 patients with the diagnosis of rheumatoid arthritis. The cardiovascular risk was calculated using the modified Framingham scale. Statistical analysis was performed using SPSS 22 considering a significant p < 0.05. Serum leptin concentrations and cardiovascular risk (CVR) factors were compared and found that there was a significant difference between higher leptin values and disease activity (p 0.047), obesity (p 0.038), positive rheumatoid factor (p 0.009), tobacco (p 0.009), and metabolic syndrome (p 0.001). Likewise, a significant relationship was found between lower leptin concentrations and hydroxychloroquine consumption (p = 0.023). We found significant difference between IL-6 concentrations and disease activity (p 0.028), hypertriglyceridemia (p 0.023), LDL-C (p 0.029), and smoking (0.005). Similarly, an association between hydroxychloroquine consumption and low concentrations of IL-6 was found (p 0.005). Framingham CVR was calculated and the result obtained was multiplied by 1.5. The 35.2% of the population studied had a low Framingham CVR, 38.9% moderate, and 25.9% presented a high risk. We compared the level of CVR and serum leptin and IL-6 concentrations, finding that the highest CVR was the leptin and IL-6 values. There is a positive association between CVR and serum leptin concentrations. It is also significantly associated with traditional and non-traditional risk factors.
Literatur
1.
Zurück zum Zitat Méndez C, Andreu J, García B, Sangüesa C (2013) Artritis reumatoide (II). Medicine 11:1850–1855 Méndez C, Andreu J, García B, Sangüesa C (2013) Artritis reumatoide (II). Medicine 11:1850–1855
3.
Zurück zum Zitat Hollan I, Meroni P, Ahearn J, Cohen J, Curran S, Goodyear C et al (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12:1004–1015CrossRefPubMed Hollan I, Meroni P, Ahearn J, Cohen J, Curran S, Goodyear C et al (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12:1004–1015CrossRefPubMed
4.
Zurück zum Zitat Skeoch S, Bruce I (2015) Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol 11:390–400CrossRefPubMed Skeoch S, Bruce I (2015) Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol 11:390–400CrossRefPubMed
5.
Zurück zum Zitat Su D, Li Z, Li X, Chen Y, Zhang Y, Ding D et al (2013) Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease. Mediat Inflamm 2013:726178 Su D, Li Z, Li X, Chen Y, Zhang Y, Ding D et al (2013) Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease. Mediat Inflamm 2013:726178
6.
Zurück zum Zitat Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF et al (2010) Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol 37:1633–1638CrossRefPubMedPubMedCentral Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF et al (2010) Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol 37:1633–1638CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Correia M, Haynes W (2004) Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 13:215–223CrossRefPubMed Correia M, Haynes W (2004) Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 13:215–223CrossRefPubMed
10.
Zurück zum Zitat Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C 3rd (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C 3rd (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed
11.
Zurück zum Zitat Söderberg S, Ahrιn B, Jansson H, Johnson O, Hallmans G, Asplund K et al (1999) Leptin is associated with increased risk of myocardial infarction. J Int Med 246:409–418CrossRef Söderberg S, Ahrιn B, Jansson H, Johnson O, Hallmans G, Asplund K et al (1999) Leptin is associated with increased risk of myocardial infarction. J Int Med 246:409–418CrossRef
12.
Zurück zum Zitat Mendoza U, Alonso M (2015) Factor reumatoide asociado con marcadores de riesgo aterogénico en pacientes con artritis reumatoide. Rev Cuba Reumatol:151–155 Mendoza U, Alonso M (2015) Factor reumatoide asociado con marcadores de riesgo aterogénico en pacientes con artritis reumatoide. Rev Cuba Reumatol:151–155
13.
Zurück zum Zitat Abdalla M, Effat D, Sheta M, Hamed WE (2014) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. The Egyptian. Rheumatologist 36:1–5 Abdalla M, Effat D, Sheta M, Hamed WE (2014) Serum leptin levels in rheumatoid arthritis and relationship with disease activity. The Egyptian. Rheumatologist 36:1–5
14.
Zurück zum Zitat Oner SY, Volkan O, Oner C, Mengi A, Direskeneli H, Tasan DA (2015) Serum leptin levels do not correlate with disease activity in rheumatoid arthritis. Acta Reumatol Port 40:50–54PubMed Oner SY, Volkan O, Oner C, Mengi A, Direskeneli H, Tasan DA (2015) Serum leptin levels do not correlate with disease activity in rheumatoid arthritis. Acta Reumatol Port 40:50–54PubMed
15.
Zurück zum Zitat Gûlkesen A, Akgol G, Tuncer T, Kal GA, Telo S, Poyraz AK et al (2016) Relationship between leptin and neopterin levels and disease activation parameters in patients with rheumatoid arthritis. Arch Rheumatol 31:333–339CrossRef Gûlkesen A, Akgol G, Tuncer T, Kal GA, Telo S, Poyraz AK et al (2016) Relationship between leptin and neopterin levels and disease activation parameters in patients with rheumatoid arthritis. Arch Rheumatol 31:333–339CrossRef
16.
Zurück zum Zitat Lee YH, Bae SC (2016) Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis. Z Rheumatol 75:1021CrossRefPubMed Lee YH, Bae SC (2016) Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis. Z Rheumatol 75:1021CrossRefPubMed
17.
Zurück zum Zitat Cao H, Lin J, Chen W, Xu G, Sun C (2016) Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: a meta-analysis and systematic review. Autoimmunity 8:547–553CrossRef Cao H, Lin J, Chen W, Xu G, Sun C (2016) Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: a meta-analysis and systematic review. Autoimmunity 8:547–553CrossRef
18.
Zurück zum Zitat Engvall I, Tengstrand B, Brismar K, Hafström I (2010) Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months. Arthritis Res Ther 12:R197CrossRefPubMedPubMedCentral Engvall I, Tengstrand B, Brismar K, Hafström I (2010) Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months. Arthritis Res Ther 12:R197CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA (2004) Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 287:182–187CrossRef Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA (2004) Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 287:182–187CrossRef
20.
Zurück zum Zitat Targońska-Stepniak B, Dryglewska M, Majdan M (2010) Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int 30:731–737CrossRefPubMed Targońska-Stepniak B, Dryglewska M, Majdan M (2010) Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int 30:731–737CrossRefPubMed
21.
Zurück zum Zitat Cruz J, Ataide H, Fereira L, Santan PS, Tavares A, Branco AL et al (2013) Hydroxychloroquine decreases Th17 related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics 68:766–771CrossRef Cruz J, Ataide H, Fereira L, Santan PS, Tavares A, Branco AL et al (2013) Hydroxychloroquine decreases Th17 related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics 68:766–771CrossRef
22.
Zurück zum Zitat Jang CH, Choi JH, Byun MS, Jue DM (2006) Chloroquine inhibits production of TNF-a, IL-1B and IL-6 from lipopolysaccharide stimulated human monocytes/macrophages by different modes. Rheumatology (Oxford) 45:703–710CrossRef Jang CH, Choi JH, Byun MS, Jue DM (2006) Chloroquine inhibits production of TNF-a, IL-1B and IL-6 from lipopolysaccharide stimulated human monocytes/macrophages by different modes. Rheumatology (Oxford) 45:703–710CrossRef
Metadaten
Titel
Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis
verfasst von
José Antonio De Jesús Batún-Garrido
Marisol Salas-Magaña
Isela Esther Juárez-Rojop
Publikationsdatum
03.11.2017
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 3/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3897-x

Weitere Artikel der Ausgabe 3/2018

Clinical Rheumatology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.